IceCure Medical (ICCM) Q2 2024 Earnings
ICCM·Reported August 20, 2024·Before market open
IceCure Medical reported Q2 2024 revenue of $1.0M, beat analyst consensus of $925.5K by $85.5K. Diluted EPS came in at $-0.06, beat the $-0.07 consensus by $0.01.
Revenue
$1.0Mbeat by $85.5K
Consensus: $925.5KDiluted EPS
$-0.06beat by $0.01
Consensus: $-0.07
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q2 2024 Earnings FAQ
Common questions about IceCure Medical's Q2 2024 earnings report.
IceCure Medical (ICCM) reported Q2 2024 earnings on August 20, 2024 before market open.
IceCure Medical reported revenue of $1.0M and diluted EPS of $-0.06 for Q2 2024.
Revenue beat the consensus estimate of $925.5K by $85.5K. EPS beat the consensus estimate of $-0.07 by $0.01.